Printer Friendly

APROGENEX, INC. COMPLETES INITIAL PUBLIC OFFERING

 HOUSTON, Oct. 22 /PRNewswire/ -- Aprogenex, Inc. (AMEX: APG) today announced the closing of an initial equity offering by the company of 1,250,000 shares of its common stock at an offering price of $8.75 per share. The underwriting was managed by H.J. Meyers & Co., Inc. The underwriters have an option until Nov. 29, 1993, to purchase an additional 187,500 shares to cover any over-allotments in the offering. The company's common stock is traded on The American Stock Exchange.
 Aprogenex develops and intends to manufacture and market diagnostic test systems based on its proprietary DNA probe technology to identify the presence or extent of genetic abnormalities and disease.
 Copies of the prospectus related to the offering may be obtained from the managing underwriter at H.J. Meyers & Co., Inc., 356 North Camden Drive, Beverly Hills, Calif. 90210.
 -0- 10/22/93
 /CONTACT: Donald Payne, chief financial officer of Aprogenex, Inc., 713-748-5114/
 (APG)


CO: Aprogenex, Inc. ST: Texas IN: MTC SU: OFR

PS -- NY039 -- 5716 10/22/93 12:01 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 22, 1993
Words:173
Previous Article:INDEPENDENCE BLUE CROSS ANNOUNCES RESULTS OF BOARD-APPROVED MINORITY PURCHASING PROGRAM
Next Article:LXE ANNOUNCES THIRD QUARTER 1993 RESULTS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters